SCHEMBL1384073

SCHEMBL1384073

CC(C)N(CCn1cc(-c2ccccc2)c(OCc2ccccc2)n1)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.47
BCHE P06276 2/20 0.47
PDE10A Q9Y233 2/20 0.41
KCNH2 Q12809 1/20 0.39
MCHR1 Q99705 1/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
LTA4H P09960 1/20 0.38
SQOR Q9Y6N5 1/20 0.38
ACHE P22303 2/20 0.37
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2579429 0.99 CNR2 (0.46) CNR2BCHEPDE10AKCNH2MCHR1
Oxalic Acid SCHEMBL2576068 0.94 CNR2 (0.43) CNR2BCHEPDE10AKCNH2MCHR1
SCHEMBL1385049 0.86 PDE10A (0.43) CNR2PDE10AKCNH2SQORACHE
Hydrochloric Acid SCHEMBL2577843 0.85 PDE10A (0.42) PDE10AKCNH2SQORGABRA1GABRG2
SCHEMBL1386845 0.84 PDE10A (0.41) BCHEPDE10AKCNH2MCHR1HTT
Hydrochloric Acid SCHEMBL2577840 0.83 PDE10A (0.41) BCHEPDE10AKCNH2MCHR1HTT
SCHEMBL1384547 0.83 PDE10A (0.42) PDE10AKCNH2MCHR1LTA4HSQOR
Hydrochloric Acid SCHEMBL2575915 0.82 POLB (0.42) PDE10AKCNH2MCHR1LTA4HSQOR
SCHEMBL6532144 0.81 PDE10A (0.39) CNR2PDE10ALMNAALDH1A1HPGD
SCHEMBL1387091 0.81 MAOB (0.46) CNR2PDE10ALMNAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4833078-B2 2011-12-07 JP claimed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP claimed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO claimed
EP-1689720-B1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2009-04-15 EP disclosed
CN-1906172-A Pyrazole derivatives as medicaments for the treatment of acute or chronic neuronal degeneration AVENTIS PHARMA SA (FR) 2007-01-31 CN disclosed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP disclosed
WO-2005051917-A9 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2005-09-29 WO disclosed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO disclosed